TNFSF10 and fibrosarcoma: In one of the latest works on the topic, these double-edged lipid nanoparticles demonstrated the concerted action of the liposomal DOX and TRAIL in a fibrosarcoma HT1080-xenograft model without systemic toxicity in vivo [50].